Cost analysis of sofosbuvir/ribavirin versus sofosbuvir/simeprevir for genotype 1 hepatitis C virus in interferon-ineligible/intolerant individuals

Brief Communication: The Relationship of Regression of Cirrhosis to Outcome in Chronic Hepatitis C

(2013) Vincent Mallet et al.   ANNALS OF INTERNAL MEDICINE

New Protease Inhibitors for the Treatment of Chronic Hepatitis C

(2013) Shan Liu et al.   ANNALS OF INTERNAL MEDICINE

Baseline Hepatitis C Virus (HCV) NS3 Polymorphisms and Their Impact on Treatment Response in Clinical Studies of the HCV NS3 Protease Inhibitor Faldaprevir

(2013) Kristi L. Berger et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics

(2013) Anuoluwapo Osinusi et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

845 ONCE DAILY SOFOSBUVIR PLUS RIBAVIRIN FOR 12 AND 24 WEEKS IN TREATMENT-NAÏVE PATIENTS WITH HCV INFECTION: THE QUANTUM STUDY

(2013) J.P. Lalezari et al.   JOURNAL OF HEPATOLOGY

1425 SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR CHRONIC HCV GENOTYPE-1 INFECTION IN TREATMENT-NAÏVE PATIENTS: RESULTS FROM QUEST-1, A PHASE III TRIAL

(2013) I. Jacobson et al.   JOURNAL OF HEPATOLOGY

All-oral, interferon-free treatment for chronic hepatitis C: cost-effectiveness analyses

(2013) L. M. Hagan et al.   JOURNAL OF VIRAL HEPATITIS

Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial

(2013) Eric Lawitz et al.   LANCET

HCV direct-acting antiviral agents: the best interferon-free combinations

(2013) Raymond Schinazi et al.   LIVER INTERNATIONAL

Cost-effectiveness and Population Outcomes of General Population Screening for Hepatitis C

(2012) Phillip O. Coffin et al.   CLINICAL INFECTIOUS DISEASES

Distribution of hepatitis C virus genotypes in a diverse US integrated health care population

(2012) M. Michele Manos et al.   JOURNAL OF MEDICAL VIROLOGY

Sustained Virologic Response to Antiviral Therapy for Chronic Hepatitis C Virus Infection: A Cure and So Much More

(2011) B. L. Pearlman et al.   CLINICAL INFECTIOUS DISEASES

All-Cause, Liver-Related, and Non-Liver-Related Mortality Among HCV-Infected Individuals in the General US Population

(2011) S. S. El-Kamary et al.   CLINICAL INFECTIOUS DISEASES

A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C

(2011) Jules L. Dienstag et al.   HEPATOLOGY

Liver Transplantation in the United States, 1999-2008

(2010) P. J. Thuluvath et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Susceptibility of Treatment-Naive Hepatitis C Virus (HCV) Clinical Isolates to HCV Protease Inhibitors

(2010) A. Bae et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Survival and cost-effectiveness analysis of competing strategies in the management of small hepatocellular carcinoma

(2010) Willscott E. Naugler et al.   LIVER TRANSPLANTATION

Predicting Mortality Risk in Patients With Compensated HCV-Induced Cirrhosis: A Long-Term Prospective Study

(2009) Savino Bruno et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The effects of hepatitis C recurrence on health-related quality of life in liver transplant recipients

(2009) Hillary Bownik et al.   LIVER INTERNATIONAL

Surveillance of cirrhosis for hepatocellular carcinoma: a cost–utility analysis

(2008) J Thompson Coon et al.   BRITISH JOURNAL OF CANCER

Eradication of Hepatitis C Virus in Patients Successfully Treated for Chronic Hepatitis C

(2008) Sarah Maylin et al.   GASTROENTEROLOGY

Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression

(2008) Hla-Hla Thein et al.   HEPATOLOGY

Systematic Review: Health-State Utilities in Liver Disease: A Systematic Review

(2008) David J. McLernon et al.   MEDICAL DECISION MAKING